Sign In
Buy RBGPF
$66.00
+0 (+0%)
At Close: Jul 31, 2026
Reckitt Benckiser Group H1 Earnings Call Highlights
05:05am, Wednesday, 29'th Jul 2026
Reckitt Benckiser Group LON: RKT reported accelerating sales growth in the second quarter of 2026, supported by innovation, emerging-market demand and a return to growth in North America, while mainta
Reckitt launches £500m buyback as quarterly sales accelerate
03:02am, Wednesday, 29'th Jul 2026
Reckitt Benckiser Group PLC (LSE:RKT) has launched a new £500 million share buyback after second-quarter sales accelerated across all regions and product categories. The maker of consumer products b
Reckitt beats second-quarter sales estimates on emerging markets strength
01:56am, Wednesday, 29'th Jul 2026
Dettol maker Reckitt beat second-quarter sales growth estimates and reaffirmed its annual forecast on Wednesday, as strong demand in China, India and other emerging markets helped offset weaknes
Reckitt Benckiser sells one of its two Russian units
02:48am, Friday, 24'th Jul 2026
Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB) has agreed to sell its Russian household hygiene business more than four years after first announcing exit plans in the wake of the Ukraine in
Jefferies upgrades Reckitt to buy, arguing market has over-punished transitory setbacks
06:41am, Wednesday, 22'nd Jul 2026
Jefferies has upgraded Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB)to 'buy' from 'hold', raising its price target to 5,900p from 5,600p ahead of half-year results next week. The broker ar
Missouri jury sides with Enfamil maker Mead Johnson in case over preterm baby formula
03:06pm, Thursday, 02'nd Jul 2026
A jury in St. Louis on Thursday rejected claims that Reckitt unit Mead Johnson's specialized formula for preterm babies was to blame for causing an infant's dangerous bowel disease.
Reckitt Benckiser Bets on AI to Speed Innovation and Boost Growth
11:07pm, Thursday, 14'th May 2026
Reckitt Benckiser Group LON: RKT executives used an investor “Focus On” event to outline how the company is applying digital science, artificial intelligence and predictive modeling across its inn
Swiss bank sees upside for Reckitt Benckiser though the Dettol and Durex owner needs to "rebuild trust"
09:59am, Monday, 27'th Apr 2026
UBS sees nearly 60% total return potential in Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB with the Swiss bank repeating a Buy rating and 7,400p price target. It comes after a meeting wi
Reckitt stock dips on Q1 miss: what's really ailing the health giant?
04:28am, Wednesday, 22'nd Apr 2026
Reckitt stock fell about 5% in early trading on Wednesday after the consumer goods group said first-quarter core like-for-like net revenue rose only 1.3%. The figure was well below the 2.9% analysts h
Reckitt's Like-for-Like Revenue Rises on Emerging Markets Performance
02:50am, Wednesday, 22'nd Apr 2026
Lysol maker Reckitt Benckiser booked a rise in first-quarter like for like revenue, helped by strong emerging markets performance, where like-for-like sales grew 7.6%.
Reckitt Benckiser Group plc (RBGLY) Presents at UBS Global Consumer and Retail Conference Transcript
05:22pm, Wednesday, 11'th Mar 2026
Reckitt Benckiser Group plc (RBGLY) Presents at UBS Global Consumer and Retail Conference Transcript
Reckitt not yet rewarded for improved earnings model, says UBS after strong quarter
07:51am, Friday, 06'th Mar 2026
UBS maintained its 'buy' rating on Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB), the consumer goods company behind brands including Dettol, Nurofen and Durex, on Friday but cut its price
Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript
06:32am, Thursday, 05'th Mar 2026
Reckitt Benckiser Group plc (RBGLY) Q4 2025 Earnings Call Transcript
Reckitt beats its own targets and signals confidence in 2026 after year of strategic progress
02:51am, Thursday, 05'th Mar 2026
Consumer health group delivers core growth ahead of medium-term guidance as emerging markets surge and Essential Home disposal completes Reckitt Benckiser Group PLC (LSE:RKT, FRA:3RB, XETRA:3RB), the
Lysol Maker Reckitt Books Rise in Revenue, Boosted by Emerging Markets
02:48am, Thursday, 05'th Mar 2026
The Lysol disinfectant maker's sales grew 5% on a like-for-like basis on year, Reckitt Benckiser said.
